MRIGlobal Dx's mission is to enable the commercialization of diagnostics for improved patient outcomes.
MRIGlobal Dx provides laboratory services for CLIA-certified laboratories and
in vitro diagnostics developers.
Let MRIGlobal Dx accelerate your timeline and expand your test menu with our high quality, customized service. From early product development to FDA or CE-IVD approval, we provide scientific and laboratory services for the development of molecular diagnostic products.
In The News
Recent Press Releases/Events
MRIGlobal awarded $63 million contract for National Toxicology Program
U.S. Ambassador Robert Mikulak Named to Receive 2014 MRIGlobal Citation 5.27.2014
Thomas M. Sack Named to Kansas City Area Life Sciences Board of Directors
Society of Toxicology Recognizes MRIGlobal for 25 Years of Support at Annual Conference
MRIGlobal Dx to Attend Clinical Virology Symposium
University of Maryland School of Medicine and MRIGlobal in Collaboration Agreement
MRIGlobal Participates in One Health Summit
MRIGlobal Adds Recognized Expert in Biosurveillance and Diagnostics